FOLFOX or FOLFOX plus radiation therapy for locally advanced or metastatic esophageal squamous cell carcinoma

被引：0
|
作者：
Shiraishi, Kazuhiro [1 ]
机构：
[1] Natl Hosp Org Nagoya Med Ctr, Dept Med Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO20-4
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [21] Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    Ghosn, M.
    Saroufim, A.
    Kattan, J.
    Chahine, G.
    Nasr, F.
    Farhat, F.
    [J]. MEDICAL ONCOLOGY, 2012, 29 (04) : 2831 - 2837
  • [22] Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    M. Ghosn
    A. Saroufim
    J. Kattan
    G. Chahine
    F. Nasr
    F. Farhat
    [J]. Medical Oncology, 2012, 29 : 2831 - 2837
  • [23] Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck
    Kuhnt, Thomas
    Schreiber, Andreas
    Pirnasch, Anett
    Hautmann, Matthias G.
    Hass, Peter
    Sieker, Frank P.
    Engenhart-Cabillic, Rita
    Richter, Michael
    Dellas, Kathrin
    Dunst, Juergen
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) : 733 - 741
  • [24] Drugless therapy for locally advanced squamous cell carcinoma
    Meisterfeld, S.
    Kemper, M.
    Meier, F.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 43 - 43
  • [25] Late line FOLFOX therapy after prior cisplatin-based regimen in advanced esophageal squamous cell carcinoma: A multi-institutional retrospective study
    Shimozaki, K.
    Sugiyama, K.
    Koya, S.
    Shiraishi, K.
    Okada, M.
    Matsubara, Y.
    Furuta, M.
    Hirose, S.
    Komori, A.
    Mitani, S.
    Boku, S.
    Nishimura, T.
    Tsuchihashi, K.
    Kito, Y.
    Sugaya, A.
    Masuishi, T.
    Matsumoto, T.
    Tsuzuki, T.
    Yoshii, T.
    Hirata, K.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1481 - S1481
  • [26] Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
    Xiao-Han Zhao
    Hong-Mei Gao
    Jing-Yuan Wen
    He-Song Wang
    Luan-Ying Wu
    Chun-Yang Song
    Wen-Zhao Deng
    Shu-Chai Zhu
    Wen-Bin Shen
    [J]. Discover Oncology, 14
  • [27] Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
    Zhao, Xiao-Han
    Gao, Hong-Mei
    Wen, Jing-Yuan
    Wang, He-Song
    Wu, Luan-Ying
    Song, Chun-Yang
    Deng, Wen-Zhao
    Zhu, Shu-Chai
    Shen, Wen-Bin
    [J]. DISCOVER ONCOLOGY, 2023, 14 (01)
  • [28] The Brown University Oncology Group Experience With FOLFOX plus Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-318
    Breakstone, Rimini
    Almhanna, Khaldoun
    Raufi, Alexander
    Beard, Rachel E.
    Leonard, Kara-Lynne
    Renaud, Jennifer
    Kastura, Michaela
    Dionson, Sopha
    Wood, Roxanne
    Sturtevant, Ashlee
    Dipetrillo, Thomas
    Olszewski, Adam
    Safran, Howard
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (08): : 327 - 332
  • [29] Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer
    Schrag, D.
    Weiser, M. R.
    Goodman, K. A.
    Gonen, M.
    Cercek, A.
    Reidy, D. L.
    Temple, L. K.
    Wong, W. D.
    Paty, P.
    Saltz, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Neoadjuvant immune checkpoints inhibitors plus chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
    Kao, M-W.
    Hsieh, K-C.
    Rau, K-M.
    Ho, H-J.
    Huang, K-K.
    Kuo, Y-H.
    Hsieh, M-C.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1539 - S1539
12345